Targeted Peptide Therapy // IVUSE+

LIPO+

LIPO+ is a multi-compound lipotropic injection combining five active ingredients, Methionine, Inositol, Choline, B6, and B12, into a single dose engineered for fat processing and metabolic support.

MIC + B6 + B12

Fat Metabolism Liver Support Metabolic Balance Energy Production

Clinician-prescribed. Ships from a licensed U.S. pharmacy.

The Mechanism

Why Injectable Beats Oral

Oral lipotropic supplements lose the majority of their potency before they ever reach your bloodstream. Methionine, Inositol, and Choline must survive stomach acid, compete with food for absorption, and pass through first-pass liver metabolism, all of which degrades bioavailability significantly. B-vitamins taken orally face similar losses. The result: you absorb a fraction of what you swallow. Intramuscular injection bypasses the GI tract entirely, delivering all five compounds directly into muscle tissue for systemic absorption. This means 100% bioavailability with no digestive loss. More critically, injectable delivery ensures all five ingredients arrive simultaneously at therapeutic concentrations, creating the synergistic effect that makes LIPO+ more effective than any combination of oral supplements.

Clinical Data

The Evidence

100%

Bioavailability via intramuscular injection

Active compounds delivered simultaneously per injection

78%

Of LIPO+ patients reported noticeable improvement in sustained energy and metabolic markers within the first four weeks of weekly injections.

IVUSE+ patient survey data

Comparison

Oral Supplements vs. Injectable

Oral Supplements	Injectable
Degraded by stomach acid before absorption begins	Bypasses the GI tract entirely for 100% bioavailability
First-pass liver metabolism reduces active compound levels	All five compounds delivered directly to systemic circulation
Requires 3-5 separate pills daily to approximate the same ingredients	One injection per week replaces an entire supplement stack
Inconsistent absorption rates depending on food intake and gut health	Consistent dosing unaffected by food, gut flora, or digestive conditions
No guarantee all compounds reach therapeutic levels simultaneously	All ingredients arrive at therapeutic concentration simultaneously

Product Information

Details

Methionine is an essential amino acid that acts as a lipotropic agent, preventing excess fat buildup in the liver while supporting the breakdown of fats during metabolism. Inositol and Choline work in tandem to emulsify cholesterol and facilitate the transport of fats out of the liver, promoting efficient lipid processing and bile production. Vitamin B6 (Pyridoxine) is critical for over 100 enzymatic reactions in the body, including amino acid metabolism and glycogen breakdown. Cyanocobalamin (B12) drives red blood cell formation and neurological function while playing a direct role in energy production at the cellular level. Together, these five compounds create a synergistic lipotropic stack that addresses fat metabolism from multiple pathways simultaneously.

Mobilizes stored fat by enhancing hepatic lipid transport, helping the body process and eliminate fat more efficiently. Supports liver detoxification through methionine and choline pathways, reducing fat accumulation in liver tissue. Promotes metabolic rate optimization via B-vitamin cofactors that drive cellular energy production and glycogen utilization. Sustains energy output through B12-driven red blood cell formation and improved oxygen delivery to tissues.

Administer Subcutaneously. Rotate injection sites each week to minimize tissue irritation. Store refrigerated at 36-46°F (2-8°C). Protect from light. Do not freeze. Allow vial to reach room temperature for 5-10 minutes before injection. Discard if solution appears discolored or contains particulate matter. Each vial contains a 30-day supply (4 doses).

Common side effects include mild soreness, redness, or swelling at the injection site. Some patients report temporary warmth or flushing after injection. Mild nausea or stomach discomfort may occur in the first 1-2 doses as the body adjusts. Less common side effects include headache, lightheadedness, or mild diarrhea. These typically resolve within 24-48 hours. Contact your prescribing provider if side effects persist beyond 48 hours or if you experience signs of allergic reaction including hives, difficulty breathing, or swelling of the face and throat.

Disclaimer and Transparency

Important Information About Compounded Injectables

Compounded medications are not reviewed or approved by the FDA and do not undergo the same pre-market evaluation as FDA-approved drugs.
IVUSE peptide injections are prepared using peptide ingredients by FDA-registered, U.S.-licensed 503A & 503B compounding pharmacies, where available and clinically appropriate.
Availability and formulation may vary based on state regulations, evolving clinical guidance, and pharmacy partners.

All prescriptions, treatment decisions, and care plans are made independently by licensed healthcare providers using their professional judgment. Images and product depictions are for illustration only; actual packaging and supplies may vary.

*If you are interested in a prescription product, IVUSE will coordinate a telehealth visit with a licensed medical provider who will determine whether you are an appropriate candidate based on your health profile and current standards of care. If approved, a prescription will be issued and filled by one of our partner pharmacies. All prescriptions are subject to provider discretion and clinical appropriateness.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. All information provided here is for educational purposes only and does not replace personalized medical advice from a qualified healthcare professional.

Stop the medication and contact your provider if you experience persistent or concerning symptoms. Seek immediate medical care if you develop signs of a severe allergic reaction (such as hives, facial swelling, or difficulty breathing) or any rapidly worsening symptom.